Improved survival trend of patients with hepatocellular carcinoma at an Australian tertiary hospital between 1995-2009

N. Wong, A. Haydon, W. Kemp, P. Wijeratne, S. Roberts

Research output: Contribution to journalArticleResearchpeer-review

8 Citations (Scopus)


Aim: To evaluate trends in survival of patients with hepatocellular carcinoma (HCC) at The Alfred over a 15-year period from 1995-2009 Methods: A retrospective cohort study of patients with HCC comparing epidemiology, clinical presentation, treatment parameters and overall survival of those diagnosed between 1995-2001 and 2002-2009. Overall survival of patients with primary liver cancer. Results: The study population consisted of 215 patients; 110 diagnosed between 1995-2001 (Cohort A) and 105 between 2002-2009 (Cohort B). Overall survival increased significantly between 1995-2010 (P = 0.016); median survival was 365 days in Cohort A compared with 665 in Cohort B. The improvement in survival was associated with an increase in the proportion of cases detected at an asymptomatic stage (P = 0.012), a decline in the severity of liver disease at diagnosis (P = 0.002) and increased utilisation of loco-regional therapy (P = 0.001) over the same period. Survival of patients detected through screening was significantly higher than those detected through non-screening methods (1309 vs 233 days, P < 0.001). Conclusions: The survival of patients with HCC managed at a tertiary referral centre has improved over the period 1995-2009. This improvement may relate to the increased detection of the disease at an asymptomatic stage (e.g. through screening) as well as increased utilisation of effective loco-regional therapies for HCC.

Original languageEnglish
Pages (from-to)197-203
Number of pages7
JournalInternal Medicine Journal
Issue number2
Publication statusPublished - 1 Feb 2013


  • Hepatocellular carcinoma
  • Screening
  • Survival

Cite this